目的 探討苯磺酸左旋氨氯地平治療高血壓的臨床效果。方法 124 例高血壓患者隨機分為對照組與治療組,每組62 例。對照組給予硝苯地平緩釋片10 mg/次,2 次/d;治療組給予苯磺酸左旋氨氯地平2.5 mg/次,1 次/d,兩組患者均治療12 周,比較兩組的治療效果及治療前后血壓變化及不良反應(yīng)發(fā)生情況。結(jié)果 治療組總有效率為93.5%,明顯高于對照組的80.6%,不良反應(yīng)發(fā)生率為4.8%,明顯低于對照組的16.1%,兩組比較差異顯著(P< 0.05);治療后,治療組舒張壓、收縮壓優(yōu)于對照組,且差異顯著(P< 0.05)。結(jié)論 苯磺酸左旋氨氯地平治療高血壓的臨床效果顯著,可有效改善患者臨床癥狀,降低患者血壓,安全性高,不良反應(yīng)少,是治療高血壓的理想選擇。

Objective To explore clinical efficacy of Levamlodipine Besylate Tablets for the treatment of hypertension. Methods One hundred and twenty-four patients with hypertension were selected as research subjects, who were divided into the control group and the observation group with 62 cases in each group according to different treatment methods. Patients in the control group were subjected to the treatment of Sustained-release Nifedipine Tablets, and patients in the observation group were subjected to the treatment of Levamlodipine Besylate Tablets, the treatment efficacy and the change in blood pressure and the occurrence of adverse reaction of patients before and after treatment were compared and analyzed. Results The total effective rate of treatment for patients in the observation group was 93.5%, being significantly higher than that in the control group at 80.6%, and the incidence of adverse reactions of patients in the observation group was 4.8%, being significantly lower than that in the control group at 16.1%, with significant difference (P <0.05). Diastolic blood pressure and systolic blood pressure of patients in the observation group after treatment were better than those in the control group, and the difference was significant (P <0.05). Conclusion Levamlodipine Besylate Tablets delivers significant efficacy in the treatment of hypertension, it can effectively improve clinical symptoms of patients, reduce the blood pressure of patients, and it is an ideal choice for the treatment of hypertension with high safety and less adverse reaction, being worthy of popularization.